Skip to content
PubMed This is a summary of 7 peer-reviewed journal articles Updated
Thoracic Surgery

Building Your Care Team: The Specialized Approach

At a Glance

Treating pleural mesothelioma requires a specialized multidisciplinary tumor board at a high-volume cancer center. Your core team should include a thoracic pathologist, thoracic surgeon, medical oncologist, and radiation oncologist to ensure an accurate diagnosis and effective treatment plan.

Because pleural mesothelioma is a rare and aggressive disease, the quality of your care depends almost entirely on the expertise of the people treating you [1]. Research shows that patients who receive treatment at high-volume centers—hospitals that specialize in mesothelioma—often have better survival outcomes and fewer complications than those treated at local community hospitals [2].

The Power of the Multidisciplinary Tumor Board

The “gold standard” for mesothelioma care is a Multidisciplinary Tumor Board (MDTB) [2]. This is not just a single doctor, but a formal meeting where a group of specialists sit down together to review your specific scans, pathology, and health history to build a unified plan [3].

Instead of one doctor guessing the best path forward, you benefit from the collective wisdom of several experts at once [2]. Current guidelines from major cancer organizations state that this coordinated approach is absolutely essential for a disease as complex as mesothelioma [2][3].

Key Members of Your Care Team

A specialized team should include at least these four core experts:

  • Thoracic Pathologist: Mesothelioma is notoriously difficult to diagnose. A pathologist who specializes in chest cancers is critical for ensuring your diagnosis (and subtype) is 100% accurate, often using specialized tests like BAP1 and MTAP [1][4].
  • Thoracic Surgeon: This is a surgeon who specializes in the chest cavity. In a high-volume center, they perform complex, lung-sparing procedures (like Pleurectomy/Decortication) frequently, which is linked to better safety [5].
  • Medical Oncologist: This doctor manages systemic treatments like chemotherapy and immunotherapy [3]. They stay up-to-date on the latest trial results (like CheckMate 743) and know how to manage the side effects of these drugs [6].
  • Radiation Oncologist: If radiation is part of your plan, you need an expert who knows how to target the pleura (lung lining) while protecting the sensitive lung and heart tissue nearby [7].

The Timeline: What to Expect

For a newly diagnosed patient, waiting for answers can be agonizing. Knowing the typical timeline can help set expectations:

  1. Biopsy and Pathology: Once a tissue sample is taken, specialized immunohistochemistry (IHC) staining takes time. It can take 1 to 2 weeks for a full pathology report to be finalized [1].
  2. Tumor Board Review: After the pathology is confirmed and all PET/CT scans are completed, the multidisciplinary tumor board meets to review the case [2]. This can take an additional week.
    While the wait is difficult, getting the diagnosis exactly right before starting treatment is crucial for your long-term success.

If your current hospital does not have a formal mesothelioma multidisciplinary team, you have the right to request a second opinion at an NCI-designated or high-volume cancer center [2].

Common questions in this guide

Why is it important to go to a high-volume center for pleural mesothelioma?
High-volume centers specialize in treating complex cancers like mesothelioma. Research shows that patients treated at these specialized hospitals often have better survival outcomes and fewer complications compared to those treated at local community hospitals.
What is a multidisciplinary tumor board?
A multidisciplinary tumor board is a formal meeting where a team of different medical specialists reviews your scans, pathology, and health history. Rather than relying on one doctor, this collaborative approach ensures you receive a unified and comprehensive treatment plan.
Who should be on my mesothelioma care team?
Your core care team should include a thoracic pathologist for accurate diagnosis, a thoracic surgeon for complex procedures, a medical oncologist to manage systemic treatments like chemotherapy, and a radiation oncologist.
How long does it take to get a mesothelioma treatment plan?
It typically takes one to two weeks for a full pathology report to be finalized after a biopsy. Following that, a multidisciplinary tumor board may take an additional week to review your case and finalize a treatment plan.
Should I get a second opinion for pleural mesothelioma?
Yes, getting a second opinion is highly recommended, especially if your local hospital lacks a formal mesothelioma multidisciplinary team. Seeking care at a high-volume cancer center can provide access to specialized surgeons and clinical trials.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many mesothelioma-specific cases does this hospital and this surgical team treat each year?
  2. 2.Will my case be reviewed by a formal multidisciplinary tumor board that includes a thoracic-specialized pathologist?
  3. 3.Who is the 'lead' coordinator for my care team—is there a nurse navigator who will help me manage appointments?
  4. 4.What experience does your radiation oncology team have in treating mesothelioma, specifically using modern techniques to protect the remaining lung?
  5. 5.Does this center offer clinical trials specifically for mesothelioma that aren't available at my local hospital?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (7)
  1. 1

    Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma.

    Lucà S, Pignata G, Cioce A, et al.

    Cancers 2025; (17(3)) doi:10.3390/cancers17030481.

    PMID: 39941848
  2. 2

    Treatment of Pleural Mesothelioma: ASCO Guideline Update.

    Kindler HL, Ismaila N, Bazhenova L, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2025; (43(8)):1006-1038 doi:10.1200/JCO-24-02425.

    PMID: 39778125
  3. 3

    Malignant pleural mesothelioma: The disdained member of thoracic oncology!

    Khosla D, Singh PK, Chhabria BA, et al.

    World journal of experimental medicine 2024; (14(3)):91739 doi:10.5493/wjem.v14.i3.91739.

    PMID: 39312698
  4. 4

    Diagnostic performance of immunohistochemistry markers for malignant pleural mesothelioma diagnosis and subtypes. A systematic review and meta-analysis.

    Parra-Medina R, Castañeda-González JP, Chaves-Cabezas V, et al.

    Pathology, research and practice 2024; (257()):155276 doi:10.1016/j.prp.2024.155276.

    PMID: 38603842
  5. 5

    Short-term outcomes of pleurectomy decortication and extrapleural pneumonectomy in mesothelioma.

    van Gerwen M, Wolf A, Liu B, et al.

    Journal of surgical oncology 2018; (118(7)):1178-1187 doi:10.1002/jso.25260.

    PMID: 30293239
  6. 6

    Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743.

    Scherpereel A, Baas P, Nowak AK, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2026; (44(9)):742-749 doi:10.1200/JCO-25-01328.

    PMID: 41734361
  7. 7

    Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.

    Kindler HL, Ismaila N, Armato SG, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018; (36(13)):1343-1373 doi:10.1200/JCO.2017.76.6394.

    PMID: 29346042

This page is for informational purposes only and does not replace professional medical advice. Always consult a mesothelioma specialist about your specific care team and treatment plan.

Get notified when new evidence is published on Pleural mesothelioma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.